A granulomatous conundrum: Concurrent necrobiosis lipoidica, cutaneous sarcoidosis and erythema nodosum in a nondiabetic patient

2017 ◽  
Vol 58 (4) ◽  
pp. e232-e235 ◽  
Author(s):  
Nishant Valecha ◽  
Genevieve Bennett ◽  
Leona Yip
Dermatology ◽  
2018 ◽  
Vol 235 (2) ◽  
pp. 137-143 ◽  
Author(s):  
Florian Anzengruber ◽  
Caroline Mergenthaler ◽  
Carla Murer ◽  
Reinhard Dummer

Objectives: Potassium iodide (KI) is a medication that has been used for decades in dermatology and it is mentioned as a treatment option in all major dermatology textbooks. Yet, there is little recent information on its efficacy. In our study, we wanted to retrospectively evaluate the therapy response to KI in our patients. Methods: The hospital information system was searched for patients treated with KI at the Department of Dermatology (University Hospital Zurich) in the last 20 years (January 1, 1998 to December 31, 2017). A total of 52 patients were found and, subsequently, 35 patients were included in our study. Results: KI was prescribed for the following skin conditions: erythema nodosum, disseminated granuloma anulare, necrobiosis lipoidica, nodular vasculitis, cutaneous sarcoidosis, and granulomatous perioral dermatitis/ rosacea. The median duration of KI intake was 5 ± 7.7 weeks (range 1–26). The global assessment of efficacy by the treating physician showed an improvement of disease in about a third of all patients. No response was seen in 14 patients and 9 even had a progression of disease. An adverse event was documented in 16 cases. Conclusions: Our findings show that an improvement was reached in only about a third of all cases. High response rates with only mild side effects (in 16 out of 35 patients) were observed.


2019 ◽  
Vol 19 (1) ◽  
pp. 92-94
Author(s):  
Mohamad Goldust ◽  
Ghasem Rahmatpour Rokni ◽  
Jeffrey Weinberg ◽  
Leon Kircik ◽  
Martine Bagot ◽  
...  

2016 ◽  
Vol 107 (6) ◽  
pp. 525-527
Author(s):  
J. García-Gavín ◽  
L. Comba Pérez-Pérez ◽  
L. Requena ◽  
X. Wortsman

2019 ◽  
Vol 3 (3) ◽  
pp. 219-222
Author(s):  
Allison L Limmer ◽  
Levi C Holland ◽  
Annabelle L Garcia

Necrobiosis lipoidica (NL) is a rare, granulomatous skin disease with a predilection for diabetic patients. NL can present both histopathologically and clinically in a similar fashion to other granulomatous dermatoses such as granuloma annulare, necrobiotic xanthogranuloma, and cutaneous sarcoidosis. When NL is suspected in patients without glucose intolerance, affirmative diagnosis can be difficult, and other comorbidities may be probed, as NL has been associated with conditions such as hypertension, dyslipidemia, and thyroid disorders. Familial disease has also been reported.In the following case report, we discuss a 15-year-old girl who presented with a new, single, pink atrophic plaque of the right pretibial region. Biopsy showed palisaded granulomatous inflammation within the dermis, absent dermal mucin, and rare multinucleated giant cells. This histopathologic description combined with the clinical context led to the diagnosis of necrobiosis lipoidica. The patient developed another similar lesion on the left anterior shin over the next 1.5 years which was also approached as necrobiosis lipoidica. The lesions were treated with intralesional triamcinolone acetonide and topical tacrolimus. Both lesions are now resolved with only mild atrophy of the affected areas. To date, the patient’s labs have shown no evidence of glucose intolerance, hyperlipidemia, or thyroid disorder.


2020 ◽  
pp. 83-86
Author(s):  
V. G. Akimov

Besnier-Boeck-Schaumann sarcoidosis is a multisystemic disease of unknown etiology. Only about 25 % of patients have cutaneous involvement. Every patient with cutaneous sarcoidosis should be evaluated for possible systemic sarcoidosis. This article contains descriptions and original images of clinical forms of the disease: miliary sarcoidosis, circinate sarcoidosis, nodular sarcoidosis, angiolupoid (Brocq-Potrier), lupus pernio (Besnier-Tennesson), erythema nodosum, subcutaneous sarcoidosis (Darier-Roussy). Differential diagnosis and treatment of patients are discussed.


2020 ◽  
Vol 8 (12) ◽  
pp. 2782-2786
Author(s):  
Farnaz Araghi ◽  
Mohammadreza Tabary ◽  
Azadeh Rakhshan ◽  
Sahar Dadkhahfar ◽  
Reza M. Robati

2012 ◽  
Vol 24 (1) ◽  
pp. 74 ◽  
Author(s):  
Takahito Chiba ◽  
Masakazu Takahara ◽  
Takeshi Nakahara ◽  
Shuji Fukagawa ◽  
Kenjiro Takei ◽  
...  

1975 ◽  
Vol 111 (3) ◽  
pp. 335-340 ◽  
Author(s):  
L. Forstrom
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document